Wolverine Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wolverine Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$132K	Sell	700 -2,500	-78%	-$437K	﹤0.01%	1146
2025 Q4	$544K	Sell	3,200 -3,000	-48%	-$460K	﹤0.01%	909
2025 Q3	$817K	Buy	6,200 +2,000	+48%	+$240K	0.01%	778
2025 Q2	$446K	Buy	4,200 +2,700	+180%	+$293K	﹤0.01%	897
2025 Q1	$186K	Sell	1,500 -9,600	-86%	-$1.25M	﹤0.01%	1020
2024 Q4	$1.37M	Sell	11,100 -22,900	-67%	-$2.7M	0.01%	612
2024 Q3	$3.79M	Hold	34,000	–	–	0.04%	353
2024 Q2	$3.63M	Hold	34,000	–	–	0.04%	355
2024 Q1	$4.09M	Hold	34,000	–	–	0.05%	324
2023 Q4	$4.18M	Sell	34,000 -10,400	-23%	-$1.3M	0.04%	377
2023 Q3	$5.75M	Buy	44,400 +900	+2%	+$120K	0.06%	287
2023 Q2	$5.39M	Buy	43,500 +33,100	+318%	+$4.45M	0.06%	279
2023 Q1	$1.52M	Buy	10,400 +6,100	+142%	+$902K	0.02%	586
2022 Q4	$685K	Buy	+4,300	New	+$630K	0.01%	859

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Wolverine Asset Management's JAZZ Position: Q1 2026 in Review

Wolverine Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 1,322 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #1059.

Wolverine Asset Management first reported a position in JAZZ in Q1 2020 and has held it in 12 quarters since. The position peaked at $1.69M in Q2 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Wolverine Asset Management held 1,322 shares of Jazz Pharmaceuticals worth $250K as of Q1 2026.
Wolverine Asset Management left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1059 holding.
Wolverine Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 12 quarters since.
Wolverine Asset Management's Jazz Pharmaceuticals position peaked at $1.69M in Q2 2024.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.